ALSTODT LANCE → BioRestorative Therapies, Inc. BRTX

On February 14, 2025, the Company granted to the Reporting Person a ten year option for the purchase of 791,885 shares of Common Stock of the Company at an exercise price of $2.46 per share. The option is exercisable to the extent of (a) 395,943 shares effective as of the date of grant, and (b) 395,942 shares in eight nearly equal quarterly installments commencing one year from the date of grant. Reference is made to the Incentive Stock Option Award Agreement attached hereto as Exhibit (1) for a complete description of the option granted to the Reporting Person.